期刊文献+

左亚叶酸钠原料药中两个主要杂质结构的研究 被引量:2

Structural identification of two major impurities in sodium levofolinate
下载PDF
导出
摘要 为了分离制备左亚叶酸钠原料药中两个主要杂质,并对其进行结构鉴定,建立了新的色谱系统,色谱柱为Lichrospher C18柱,流动相为乙腈-0.5%甲酸溶液(5∶95),检测波长为280 nm。利用该色谱系统将两个杂质制备出来,并对其进行LC-Q-TOF及LC-MS/MS的检测,获得两个杂质准确的相对分子质量、分子式组成及一级和二级质谱,并对准分子离子的各个产物离子进行归属,推测了两个主要杂质可能的化学结构。杂质1和杂质2的化学结构分别被鉴定为7-羟基-8-氢叶酸和10-甲酰叶酸,其中7-羟基-8-氢叶酸的结构未见文献报道。本研究所建立的方法有效地鉴定了左亚叶酸钠原料药中两个主要杂质可能的化学结构,为其质量控制提供了理论依据。 A novel HPLC method was established, which was carried out on a Lichrospher C18 column with a mobile phase consisting of aeetonitrile - O. 5% formic acid aqueous solution (5: 95) and a detection wavelength of 280 nm. Two major impurities in bulk material of sodium levofolinate were prepared by this method. Their exact molecular weights were acquired by LC-Q-TOF. Their full scan mass spectra and product ion scan mass spectra were obtained by LC-MS/MS. The fragment profiles of two target impurities were explained and their chemical structures were elucidated. Impurity 1 was identified as 7-hydroxy-8-hydrofolie acid in sodium levofolinate bulk material for the first time. Impurity 2 was identified as lO-formylfolic acid. This method is effective in identifying two major impurities in bulk material of sodium tevofolinate are useful for its quality eontroll. detected by the current HPLC method, and the results
出处 《中国药科大学学报》 CAS CSCD 北大核心 2012年第4期350-354,共5页 Journal of China Pharmaceutical University
关键词 左亚叶酸钠 杂质 结构鉴定 LC—MS/MS sodium levofolinate impurity structural identification LC-MS/MS
  • 相关文献

参考文献3

  • 1张宇佳,郑稳生.左亚叶酸钙及其片剂的HPLC测定[J].中国医药工业杂志,2005,36(9):568-569. 被引量:1
  • 2Huang K, Yang YQ. Improved preparation of calcium 5-formyl-5, 6,7 , 8-tetrahydrofolate [J]. 医药工业,1986,17(10):433-434.
  • 3European Pharmacopoeia Commission. European Pharmacopoeia 6. 0 [M]. Strasbourg , the European Directorate for the Quality of Medicines & Health Care (EDQM) ,2008: 1 380 - 1 383.

二级参考文献4

  • 1Sasaki T. Combination of levofolinate calcium and 5-fluorouracil [J]. Gan To Kagaku Ryoho, 2000, 27 (2): 315-322.
  • 2Gebbia V, Testa A, Valenza R, et al. A phase Ⅱ study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinoma [J].Oncology, 1993, 50 (6): 490-494.
  • 3Fabre E, Gallo M, Lou AC, et al. Raltitrexed/5-fluorouracilbased combination chemotherapy regimens in anti- cancer therapy [J]. Anticancer Drugs, 2001, 12 (6): 489-497.
  • 4Choi CW, Choi IK, Seo JH, et al. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas [J]. Am J Clin Oncol, 2000, 23 (4): 425-428.

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部